BDX

BDX

USD

Becton Dickinson and Company Common Stock

$179.040+1.940 (1.095%)

Reaalajas hind

Healthcare
Medical Instruments & Supplies
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$177.100

Kõrge

$180.190

Madal

$175.000

Maht

4.19M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

51.3B

Tööstusharu

Medical Instruments & Supplies

Riik

United States

Kauplemisstatistika

Keskmine maht

1.89M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $163.33Praegune $179.040Kõrge $251.99

Seotud uudised

Reuters

Waters Corp raises annual profit forecast on stronger lab equipment demand

Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on improved demand from biotech clients for its tools used in drug development and research.

Vaata rohkem
Waters Corp raises annual profit forecast on stronger lab equipment demand
PR Newswire

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient...

Vaata rohkem
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
PR Newswire

BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System

BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S. Food and Drug...

Vaata rohkem
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
PR Newswire

BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV...

Vaata rohkem
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.